Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional)
ID: 334005Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/334005

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-21-138.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is offering the Method to Extend Research in Time (MERIT) Award Extension Request, aimed at supporting Early Stage Investigators (ESIs) who currently hold an NCI ESI MERIT grant and wish to extend their research support for an additional two years. This funding opportunity is designed to provide flexibility and additional time for qualifying investigators to solidify their research careers, thereby enhancing their contributions to the field of cancer research. Eligible applicants include a diverse range of institutions and organizations, such as Historically Black Colleges and Universities (HBCUs), Tribal Colleges, and various community-based organizations, with no cost-sharing requirement. Interested applicants must adhere to strict application guidelines and submit their proposals by December 1, 2024, to ensure compliance with federal regulations; for further information, they can contact the NIH OER Webmaster at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-21-138-Full-Announcement.html
    PAR-21-138.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Cancer Institute (NCI), offers the Method to Extend Research in Time (MERIT) Award Extension Request. This funding opportunity is aimed at Early Stage Investigators (ESIs) currently holding an NCI ESI MERIT grant and seeking to extend their research support for an additional two years. The purpose is to provide flexibility and support to qualifying investigators, allowing them to solidify their research careers. Key details include application requirements, such as using the eSubmission system and adherence to specified guidelines. The funding opportunity is contingent upon NIH appropriations and the number of acceptable applications. Eligible applicants include various educational institutions and non-profit organizations. While no cost sharing is required, strict compliance with application instructions is mandatory to avoid delays or refusals. The submission process necessitates that potential applicants understand the critical evaluations that NCI staff will perform, focusing on research merit, scope consistency, and scientific importance. Lastly, applicants must fulfill all required registrations before submitting their applications to ensure they meet federal guidelines. This initiative underscores NIH's commitment to supporting emerging cancer researchers and enhancing their contributions to the field.
    Similar Opportunities
    Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Maximizing Investigators' Research Award (MIRA) aimed at Early Stage Investigators (ESIs) under the Notice of Funding Opportunity (NOFO) PAR-23-145. This grant supports a comprehensive research program within the mission of the National Institute of General Medical Sciences (NIGMS), allowing eligible researchers to apply for up to $250,000 per year for a maximum of five years, with a requirement to dedicate at least 51% of their research efforts to the program. The MIRA program is designed to enhance scientific productivity and flexibility, enabling early-career scientists to explore significant research projects without the need for preliminary data, while also promoting diversity through a required Plan for Enhancing Diverse Perspectives (PEDP). Interested applicants should note that the application deadline is February 3, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Mentored Research Scientist Development Award to Promote Diversity (K01), a federal grant aimed at enhancing diversity within the cancer research workforce. This funding opportunity supports individuals from underrepresented backgrounds in biomedical and clinical sciences by providing salary and research support for a period of 3 to 5 years under the mentorship of experienced researchers, specifically for projects that do not involve leading independent clinical trials. The initiative is crucial for addressing disparities in cancer incidence and mortality rates among underserved populations, fostering a diverse pool of research talent, and promoting innovative solutions to complex health challenges. Interested applicants must submit their proposals by November 12, 2024, and can find additional information and application guidelines at the NIH website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    The NCI Transition Career Development Award (K22 Independent Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Transition Career Development Award (K22), a federal grant aimed at supporting researchers transitioning from mentored, non-independent positions to their first independent tenure-track faculty roles in cancer research. This grant provides funding for up to three years, covering both salary and research development expenses, with the goal of enhancing the applicant's potential to secure independent NIH grants and fostering a diverse pool of capable scientists in the biomedical field. Eligible applicants include various institutions and organizations, particularly those serving underrepresented groups, and must adhere to detailed application guidelines. Interested parties can find more information and apply before the closing date of November 12, 2025, by visiting the NIH grants website or contacting NIH Grants Information at grantsinfo@nih.gov.
    Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Maximizing Investigators' Research Award (R35 - Clinical Trial Optional) to support a broad program of research within the mission of the National Institute of General Medical Sciences (NIGMS). This grant aims to enhance the efficiency and efficacy of funding by providing stability and flexibility to investigators, allowing them to pursue diverse scientific inquiries over a five-year term, with funding levels capped at $750,000 in direct costs per year and typically set at $250,000 for New Investigators. The MIRA program is designed to reduce the application burden on researchers, encourage innovation, and foster diversity in the research workforce, with applications undergoing a rigorous peer review process. Interested applicants must submit their proposals by May 16, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required), aimed at enhancing diversity within the cancer research workforce. This grant provides salary and research support for individuals from underrepresented backgrounds who are committed to leading independent clinical trials, with a focus on fostering their career development through mentorship. The program is crucial for addressing health disparities in cancer outcomes and encourages applications from those facing systemic barriers in the field. Interested applicants can receive up to $100,000 annually for salaries and an additional $30,000 for research-related expenses, with applications due by November 12, 2024. For further inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the additional information link at http://grants.nih.gov/grants/guide/pa-files/PAR-21-296.html.
    NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced the Research Specialist Award (R50), aimed at supporting laboratory-based scientists engaged in cancer research. This grant is designed for exceptional individuals who wish to continue their research within existing NCI-funded programs without transitioning to independent investigator roles, emphasizing the importance of non-tenure track scientists in sustaining the biomedical research enterprise. Eligible applicants include various higher education institutions and organizations, with funding covering salary support and travel costs for a maximum project duration of five years. The application deadline is November 1, 2024, with an anticipated project start date in March 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)," aimed at enhancing the training of a workforce to meet the nation’s biomedical and clinical research needs, particularly in cancer research. This program seeks applications that propose innovative educational activities, specifically hands-on cancer research experiences lasting 8 to 15 weeks, complemented by additional educational initiatives. With a funding ceiling of $300,000 per year for a project period of up to five years, the program encourages participation from underrepresented groups and aims to provide unique educational opportunities not covered by existing programs. Interested applicants can find more information and guidelines at the NIH website, with the application deadline set for January 25, 2026.
    NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R21 Clinical Trial Optional mechanism, aimed at supporting exploratory and developmental research in cancer diagnosis, treatment, imaging, symptom management, and prevention. This grant is designed to encourage innovative studies that challenge existing paradigms and address critical barriers in cancer research, particularly focusing on reducing disparities among underserved populations. Eligible applicants include a wide range of organizations, such as historically black colleges, tribal governments, and faith-based organizations, with a maximum funding amount of $275,000 available over a two-year period. Interested parties can find more information and application details at the provided link, with a submission deadline of July 1, 2025, and inquiries directed to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Transition Career Development Award to Promote Diversity (K22), a federal grant aimed at assisting postdoctoral fellows and individuals in equivalent positions from diverse backgrounds to transition into independent research roles in cancer research. This initiative seeks to enhance diversity within the NCI-funded cancer research workforce, specifically targeting groups underrepresented in the biomedical, behavioral, and clinical sciences, and provides up to three years of salary and research support for candidates who secure tenure-track faculty positions. The program emphasizes the importance of a diverse scientific team in addressing public health issues and requires applicants to have a terminal doctoral degree, a minimum of two years of postdoctoral training, and a clear mentorship structure, while excluding proposals that involve leading independent clinical trials. Interested applicants can find more information and apply before the closing date of January 7, 2025, by contacting the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visiting the opportunity's webpage at http://grants.nih.gov/grants/guide/pa-files/PAR-21-301.html.
    Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP) (T32)," aimed at enhancing diversity within the biomedical research workforce. This initiative seeks to support dual-degree clinician-scientist training at institutions that have historically been underrepresented in NIH-funded programs, specifically targeting Historically Black Colleges and Universities (HBCUs), Tribal Colleges and Universities (TCUs), and institutions in states eligible for the Institutional Development Award (IDeA) program. The program is designed to develop a skilled workforce capable of addressing health disparities and fulfilling the nation’s biomedical research needs, with funding available for stipends, tuition, and training-related expenses for up to five years. Interested institutions must submit their applications by January 27, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.